MedTrace Logo

A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845

NCT04673682 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2022-09-28

No results posted yet for this study

Summary

A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-845.

Conditions

  • Hypogonadism

Interventions

DRUG

D309

D309(Testosterone) 1 vial, Once, IM injection

DRUG

CKD-845

CKD-845(Testosterone) 1 vial, Once, IM injection

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Min-gul Kim, M.D., PhD. · Jeonbuk University Hospital

  • An-Hye Kim, M.D., PhD. · CHA Bundang Medical Center

  • Hyewon Chung, M.D., PhD. · Korea University Guro Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2022-05-17
Completion
2022-06-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04673682 on ClinicalTrials.gov